Inmaculada Ruiz de Mena

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

A. Carrato, J. Tabernero, M. Valladares-Ayerbes, 2019, British Journal of Cancer.

Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

C. Montagut, F. Rivera, M. Salgado, 2018, The oncologist.

Phase I/II trial of sequential treatment of nab-paclitaxel in combination with gemcitabine followed by modified FOLFOX chemotherapy in patients with untreated metastatic exocrine pancreatic cancer: Phase I results.

A. Carrato, M. Benavides, E. Aranda, 2020, European journal of cancer.